Concepedia

Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19

Alejandro Campos-Murguía, Berenice M Román-Calleja, Israel Vicente Toledo-Coronado, José A González-Regueiro, Alberto Adrián Solís-Ortega, Deyanira Kúsulas-Delint, Mariana Cruz-Contreras, Nabila Cruz-Yedra, Francisco Javier Cubero, Yulia A. Nevzorova,

Digestive and Liver Disease · 2021 · 34 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

JAMA · 2020 · 21.2K citations · Full text

, , +11

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson, Jamie S. Hirsch, Mangala Narasimhan et al. · JAMA · 2020 · 9.9K citations · Full text

, , +15

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman, Olfert Landt, Marco Kaiser et al. · Eurosurveillance · 2020 · 8.2K citations · Full text

, , +17

A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C

Chun‐Tao Wai, Joel K. Greenson, Robert J. Fontana et al. · Hepatology · 2003 · 4.4K citations · Full text

, , +16

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Jeffrey D. Browning, Lidia S. Szczepaniak, Robert L. Dobbins et al. · Hepatology · 2004 · 3.7K citations

, , +12